Literature DB >> 2974094

Hypertension in autosomal dominant polycystic kidney disease.

P E Bell1, K F Hossack, P A Gabow, J A Durr, A M Johnson, R W Schrier.   

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) has been shown to be associated with a greater than 50 percent incidence of hypertension prior to deterioration in renal function as assessed by glomerular filtration rate. The present study provides evidence for increased cardiac pre-load, as assessed by plasma atrial natriuretic factor (ANF) and cardiac index, in hypertensive as compared to normotensive ADPKD. The hypertensive ADPKD patients exhibited an increased renal vascular resistance as compared to the normotensive patients in spite of comparable glomerular filtration rates. It is hypothesized that the renal involvement of hypertensive ADPKD patients causes an impaired renal response to the observed increase in cardiac index, and also may release a venoconstrictor (such as angiotensin) which contributes to the enhanced cardiac pre-load and thus the hypertension.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2974094     DOI: 10.1038/ki.1988.233

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  12 in total

1.  Blood pressure and survival in long-term hemodialysis patients with and without polycystic kidney disease.

Authors:  Miklos Z Molnar; Lilia R Lukowsky; Elani Streja; Ramanath Dukkipati; Jennie Jing; Allen R Nissenson; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  J Hypertens       Date:  2010-12       Impact factor: 4.844

2.  Genetic and clinical studies in autosomal dominant polycystic kidney disease type 1 (ADPKD1).

Authors:  E Coto; S Aguado; J Alvarez; M J Menéndez Díaz; C López-Larrea
Journal:  J Med Genet       Date:  1992-04       Impact factor: 6.318

Review 3.  Potential pharmacological interventions in polycystic kidney disease.

Authors:  Amirali Masoumi; Berenice Reed-Gitomer; Catherine Kelleher; Robert W Schrier
Journal:  Drugs       Date:  2007       Impact factor: 9.546

4.  Genetic linkage studies of autosomal dominant polycystic kidney disease: search for the second gene in a large Sicilian family.

Authors:  S Kumar; W J Kimberling; P A Gabow; J B Kenyon
Journal:  Hum Genet       Date:  1991-06       Impact factor: 4.132

5.  Kidney dysfunction following adrenalectomy in autosomal dominant polycystic kidney disease complicated with primary aldosteronism: A case report.

Authors:  Hiroyuki Hirai; Makoto Kanno; Tsuyoshi Watanabe; Hiroaki Satoh
Journal:  Exp Ther Med       Date:  2017-06-13       Impact factor: 2.447

6.  Effect of statin therapy on disease progression in pediatric ADPKD: design and baseline characteristics of participants.

Authors:  Melissa A Cadnapaphornchai; Diana M George; Amirali Masoumi; Kim McFann; John D Strain; Robert W Schrier
Journal:  Contemp Clin Trials       Date:  2011-01-23       Impact factor: 2.226

7.  Nephron-Specific Disruption of Polycystin-1 Induces Cyclooxygenase-2-Mediated Blood Pressure Reduction Independent of Cystogenesis.

Authors:  Jayalakshmi Lakshmipathi; Yang Gao; Chunyan Hu; Deborah Stuart; Jonathan Genzen; Nirupama Ramkumar; Donald E Kohan
Journal:  J Am Soc Nephrol       Date:  2020-04-16       Impact factor: 10.121

Review 8.  Glomerular function reserve and sodium sensitivity.

Authors:  Genjiro Kimura
Journal:  Clin Exp Nephrol       Date:  2005-06       Impact factor: 2.801

Review 9.  Surgical cyst decortication in autosomal dominant polycystic kidney disease.

Authors:  Melissa Millar; Youssef S Tanagho; Mohammed Haseebuddin; Ralph V Clayman; Sam B Bhayani; R Sherburne Figenshau
Journal:  J Endourol       Date:  2013-02-05       Impact factor: 2.942

10.  Increased left ventricular mass in children with autosomal dominant polycystic kidney disease and borderline hypertension.

Authors:  Melissa A Cadnapaphornchai; Kim McFann; John D Strain; Amirali Masoumi; Robert W Schrier
Journal:  Kidney Int       Date:  2008-08-20       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.